The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes for adults with KMT2A-r acute myeloid leukemia treated with venetoclax plus azacitidine (Ven/Aza) or intensive chemotherapy (IC): A single-center retrospective study.
 
Amritpal Singh
No Relationships to Disclose
 
Grace Bosma
No Relationships to Disclose
 
Jingjing Zhang
No Relationships to Disclose
 
Diana Abbott
No Relationships to Disclose
 
Maria Amaya
No Relationships to Disclose
 
Andrew Kent
No Relationships to Disclose
 
Mathew Angelos
No Relationships to Disclose
 
Marc Schwartz
Consulting or Advisory Role - Autolus; Kite, a Gilead company
 
Jonathan Gutman
No Relationships to Disclose
 
Daniel Pollyea
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Arcellx; AstraZeneca; Bristol-Myers Squibb; Genentech; Gilead Sciences; ImmunoGen; Janssen; Karyopharm Therapeutics; Novartis; Syndax; Syros Pharmaceuticals
 
Christine McMahon
Consulting or Advisory Role - Kura Oncology; Syndax
Research Funding - Syndax (Inst); Syros Pharmaceuticals (Inst)